ViralClear adds St. David’s HealthCare in Austin, Texas, to its Planned Phase II trial for its Broad-Spectrum Oral Anti-Viral Candidate for COVID-19

Randomized, double-blind, placebo-controlled Phase II trial of merimepodib to be conducted in adults with COVID-19 who are hospitalized and require supplemental oxygen or are on non-invasive ventilation or high-flow oxygen devices   Westport, CT – June 5, 2020 — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its majority owned subsidiary, ViralClear Pharmaceuticals, […]

Drone Delivery Services Provide Much-Needed Supplies to Rural Communities

FN Media Group Presents Market Commentary   New York, NY – June 5, 2020 – Since the beginning of the pandemic, drone delivery services have served an important role in combating the spread of the virus and providing much-needed services and supplies to people in rural communities. United Parcel Service Inc. (NYSE:UPS), which became […]